1. LBA18_PRDurable clinical benefit with nivolumab (NIVO) plus low-dose ipilimumab (IPI) as first-line therapy in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC). (23rd October 2018) Authors: Lenz, H-J J; Van Cutsem, E; Limon, M L; Wong, K Y; Hendlisz, A; Aglietta, M; Garcia-Alfonso, P; Neyns, B; Luppi, G; Cardin, D; Dragovich, T; Shah, U; Atasoy, A; Postema, R; Boyd, Z; Ledeine, J-M; Overman, M; Lonardi, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0223 Anti-ccp is an independent predictor of 12-month eular response in patients with ra treated with abatacept. (15th June 2017) Authors: Broeder, A den; Kerstens, T; Fransen, J; Ende, C van den; Tweehuysen, L; Postema, R; Alemao, E; Hoogen, F van den Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 568 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0397 Abatacept shows better sustainability than tnf inhibitors when used following initial biologic dmard failure in the treatment of rheumatoid arthritis: 8 years of real-world observations from the rhumadata® clinical database and registry. (15th June 2017) Authors: Choquette, D; Bessette, L; Alemao, E; Haraoui, B; Massicotte, F; Mtibaa, M; Muratti, E; Pelletier, J-P; Postema, R; Raynauld, J-P; Rémillard, M-A; Sauvageau, D; Turcotte, A; Villeneuve, Έ; Coupal, L Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0626 Cost-effectiveness of early treatment of acpa positive rheumatoid arthritis patients with abatacept. (15th June 2017) Authors: Neubauer, AS; Minartz, C; Herrmann, KH; Postema, R; Baerwald, C Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0230 Retention rates of tnf inhibitors and abatacept used as a first biologic dmard in the treatment of rheumatoid arthritis: 8 years of experience from the rhumadata® registry. (15th June 2017) Authors: Choquette, D; Bessette, L; Alemao, E; Haraoui, B; Massicotte, F; Mtibaa, M; Muratti, E; Pelletier, J-P; Postema, R; Raynauld, J-P; Rémillard, M-A; Sauvageau, D; Turcotte, A; Villeneuve, Έ; Coupal, L Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗